Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
2031studies shown
Showing 25-36 of 2,031
Drug study icon
RecruitingNCT06966401

NBI-1065845 for depression

This study is recruiting in the United States, in the United Kingdom, in Belgium, .... It is testing NBI-1065845 for depression.

Multiple locations, including Huntsville
Why is this study shown?

This study is directly about Depression.

DepressionDrugA study involving a medication or substance.Over 18 Years
Countries
United States, United Kingdom, Belgium, ...
Sponsor
Neurocrine Biosciences
Condition
Depression
Drug study icon
RecruitingNCT06911112

NBI-1065845 for depression

This study is recruiting in the United States. It is testing NBI-1065845 for depression.

Multiple locations, including Huntsville
Why is this study shown?

This study is directly about Depression.

DepressionDrugOver 18 Years
Countries
United States
Sponsor
Neurocrine Biosciences
Condition
Depression
Drug study icon
RecruitingNCT06963021

NBI-1065845 for depression

This study is recruiting in the United States, in Canada, in the United Kingdom, .... It is testing NBI-1065845 for depression.

Multiple locations, including Chino
Why is this study shown?

This study is directly about Depression.

DepressionDrugOver 18 Years
Countries
United States, Canada, United Kingdom, ...
Sponsor
Neurocrine Biosciences
Condition
Depression
Behavioral study icon
RecruitingNCT05757791

Sodium-Glucose Cotransporter-2 Inhibitor (SGLT2) in Major Depressive Disorder (MDD)

This study is looking at whether Empagliflozin can help people with depression. Participants receive a study treatment and complete follow-up visits and assessments.

In New York
Why is this study shown?

This study is directly about Depression.

DepressionBehavioralFrom 18 Years to 65 Years
Countries
United States
Sponsor
NYU Langone Health
Condition
Depression
Drug study icon
RecruitingNCT06786624

NBI-1065845 for depression

This study is recruiting in the United States. It is testing NBI-1065845 for depression.

Multiple locations, including Little Rock
Why is this study shown?

This study is directly about Depression.

DepressionDrugOver 18 Years
Countries
United States
Sponsor
Neurocrine Biosciences
Condition
Depression
Drug study icon
RecruitingNCT07065240

SPT-300 (GlyphAllo) for depression

This study is recruiting in the United States, in Bulgaria, in Czechia, .... It is testing SPT-300 (GlyphAllo) for depression.

Multiple locations, including Chino
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 65 Years
Countries
United States, Bulgaria, Czechia, ...
Sponsor
Seaport Therapeutics
Condition
Depression
Drug study icon
RecruitingNCT06958692

A study of Dextromethorphan and Bupropion Sustained-Release Tablets in people with Major Depressive Disorder

This study is comparing Dextromethorphan and Bupropion Sustained-Release Tablets with placebo for people with depression. Participants receive Dextromethorphan and Bupropion Sustained-Release Tablets or placebo and complete study visits and assessments.

In Beijing
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 65 Years
Countries
China
Sponsor
CSPC Ouyi Pharmaceutical Co., Ltd.
Condition
Depression
Biological study icon
RecruitingNCT06692361

Fecal Microbiota Transplantation (FMT) for depression

This study is recruiting in China. It is testing Fecal Microbiota Transplantation (FMT) for depression.

Multiple locations, including Wuhu
Why is this study shown?

This study is directly about Depression.

DepressionBiologicalFrom 18 Years to 65 Years
Countries
China
Sponsor
Gang Wang
Condition
Depression
Drug study icon
RecruitingNCT06698666

Efficacy of Statins Among Major Depressive Disorder

This study is comparing Rosuvastatin 10 mg tablet with The Control Group for people with depression or Mdd. Participants receive Rosuvastatin 10 mg tablet or The Control Group and complete study visits and assessments.

In Cairo
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 20 Years to 45 Years
Countries
Egypt
Sponsor
Ain Shams University
Condition
Depression
Drug study icon
RecruitingNCT06830044

Milsaperidone for depression

This study is recruiting in the United States, in Bulgaria, in Czechia, .... It is testing milsaperidone for depression.

Multiple locations, including Phoenix
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 65 Years
Countries
United States, Bulgaria, Czechia, ...
Sponsor
Vanda Pharmaceuticals
Condition
Depression
Drug study icon
RecruitingNCT07474363

Gender Differences in Depression Severity, Gender-Sensitive Symptoms, Resilience, and Stigma in Major Depressive Disorder

This observational study is following people with depression to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.

In Eskişehir
Why is this study shown?

This study is directly about Depression.

DepressionOtherFrom 18 Years to 65 Years
Countries
Türkiye
Sponsor
Eskisehir Osmangazi University
Condition
Depression
Drug study icon
RecruitingNCT07088380

Ketamine Augmentation of ECT in Treatment-Resistant Depression

This study is looking at whether Ketamine Hydrochloride can help people with depression or Treatment Resistant Depression. Participants take part in Ketamine Hydrochloride and complete follow-up assessments.

In Milan
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 70 Years
Countries
Italy
Sponsor
Università Vita-Salute San Raffaele
Condition
Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.